CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
25 hedge funds and large institutions have $46.3M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$906K | |
| 2 | +$39.6K | |
| 3 | +$37.6K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.73K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.43K |
Top Sellers
| 1 | -$971K | |
| 2 | -$145K | |
| 3 | -$103K | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$99K |
| 5 |
HF
HRT Financial
New York
|
-$72K |